Although surgery has become much safer, it has also becoming increasingly more complex and perioperative complications continue to impact millions of patients worldwide each year. Perioperative hemodynamic optimization utilizing Goal Directed Therapy (GDT) has attracted considerable interest within the last decade due to its ability to improve postoperative short and long-term outcomes in patients undergoing higher risk surgeries. The concept of GDT in this context can be loosely defined as collecting data from minimally invasive hemodynamic monitors with the intention of using such data (flow-related parameters and/or dynamic parameters of fluid responsiveness) to titrate therapeutic interventions (intravenous fluids and/or inotropic therapy administration) with the ultimate aim of optimizing end organ tissue perfusion. Recently, the increasing amount of evidence supporting the implementation of GDT strategies has been considered so robust as to allow for the creation of national recommendations in the United Kingdom (UK), France, and Europe. These recommendations from such influential scientific societies and the potential clinical and economic benefits of GDT protocols need to also be examined within the current shift from a "pay for service" to a "pay for performance" health care system. This shift is strongly encouraged within emerging systems such as the Perioperative Surgical Home (PSH) paradigm from the United States. As a result, hospitals and clinicians around the world have become increasingly incentivized to implement perioperative hemodynamic optimization using GDT strategies within their departments. Unfortunately, its adoption continues to be quite limited and a lack of standardized criteria for perioperative fluid administrations has resulted in significant clinical variability among practitioners. This current review will provide a brief up-to-date overview of GDT, discuss current clinical practice, analyze why implementation has been limited and finally, describe the newer closed-loop GDT concept along with its potential risks and benefits.
It has been estimated that approximately 240 million anaesthesia procedures are completed worldwide every year [1] . Of these, approximately 10%, or 24 million, are conducted on "high risk" surgical patients. However, this subset disproportionally accounts for more than 80% of perioperative mortality [2] . Moderate risk surgery is much more common as it represents approximately 40% of annual procedures, or 96 million patients. Thankfully, most of these patients continue on to have an uncomplicated postoperative course. However, it is estimated that approximately 30% of these moderate risk surgeries, or 29 million patients a year, end up having a "minor" postoperative complication (most commonly a gut injury inducing delayed enteral feeding, abdominal distension, nausea, vomiting or wound complica-tions) [3] . Even if these complications are said to be "minor", they still lead to increased postoperative treatment, length of stay in the hospital and overall costs related to the perioperative management. A recent international trial ("EUSOS" study) in non-cardiac surgical patients demonstrated that the mortality rate was high (4%) and varied substantially across European countries, suggesting the need for national and international guidelines to improve postoperative outcomes [4] . We currently know that most of this documented post-operative morbidity is related to tissue hypoperfusion [3, 5] . As such, one of the most critical goals of the physician in the operating room (OR) or intensive care unit (ICU) is to correct hypovolemia and maintain adequate tissue perfusion via the optimization of fluid management. To achieve this goal, as stated by Arthur Guyton in his Textbook of Medical Physiology, one needs "an adequate perfusion pressure in order to force blood into the capillaries of all organs and an adequate cardiac output to deliver oxygen and substrates, and to remove carbon dioxide and other metabolic products" [6, 7] . However, while blood pressure monitoring is part of the American Society of Anesthesiologists (ASA) guidelines for basic monitoring [8] , a recent international survey has demonstrated that cardiac output and other relevant hemodynamic parameters are rarely monitored, even during high-risk surgery [9] .
Fluid administration: where are we coming From?
Throughout the developed and developing world most anaesthesiologists commonly use their clinical experience in conjunction with formulas of fixed-volume calculations such as the "4−2−1" rule [10] , alongside other basic traditional static variables (e.g. heart rate, blood pressure, central venous pressure and urine output), to guide their perioperative fluid administration [11] . Unfortunately, although these variables are considered important components of a global patient assessment, they have consistently been shown to be poor predictors of fluid responsiveness (defined as the percent change in stroke volume induced by volume expansion) [11] . This is because such static signs of hypovolemia (tachycardia, hypotension, and oliguria) may be present in normovolemia and absent in hypovolemia. Resulting confusion and poor management can lead to adverse clinical outcomes related to either hypovolemia or hypervolemia (Table 1) . Both of these sets of complications can potentially cause a decrease in oxygen delivery to the tissues which can then lead to an increase in postoperative morbidity (Fig. 1 ) [12] . In addition, Le Manach et al. recently demonstrated that blood pressure changes could not be used to track stroke volume changes induced by volume loading [13] . They also revealed that the relationship between arterial pressure, ventricular stroke volume, and venous return is not simple and certainly not linear. Consequently, cardiac output optimization in the operating room (which relies heavily on the idea that fluid administration increases venous return) cannot be optimally performed with standard basic monitoring parameters, such as arterial pressure and heart rate.
Fluid responsiveness And GdT: where Are we?
Moving beyond such static indices, newer dynamic parameters relying on cardiopulmonary interactions in mechanically ventilated patients under general anaesthesia have been developed since the year 2000 [14, 15] . They are increasingly being used to evaluate volume status as they have consistently been shown to be superior to static parameters for the prediction of fluid responsiveness [16] . These dynamic variables can be obtained using a variety of modern cardiac output (CO) monitoring technologies which have rapidly evolved from being very invasive to minimally invasive [12, 17, 18] . Such devices are beginning to allow for the widespread practice of accurate perioperative hemodynamic optimization. However, as with many novel technologies, clinicians are still unsure about how and which of them to use in their daily practice. Moreover, these dynamic parameters of fluid responsiveness have several limitations that need to be known and understood before such variables can be adequately utilized in a clinical setting. Firstly, these variables have to be used in mechanically ventilated patients undergoing general 
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May cause coagulation disturbances through hemodilution May also lead to vasopressor agent administration which may increase hypo perfusion and ischemia [102] Is associated with increased dail y fluid balance and mortalit y [103] . Chappell et al. also demonstrates a relationship between weight gain related to excessive fluid administration and mortality [104] anaesthesia as studies performed in spontaneously breathing patients failed to demonstrate that pulse pressure variation (PPV) can predict fluid responsiveness [19] . Moreover, tidal volume has an impact on the predictive value of PPV and a tidal volume of 8 mL kg -1 of body weight is generally required [20] , although adjustments in the cut off value for PPV can be made in patients with smaller tidal volumes. Additionally, patients have to be in sinus rhythm with their chest closed (open chest, as well as open pericardium strongly modify the cardiopulmonary interactions), while intra-abdominal pressure has to be within normal ranges [21] . One should also keep in mind that around 40 % of all patients undergoing surgical procedures in the operating room met the strict criteria for the monitoring of fluid responsiveness using PPV [22] and that, despite its strong predictive value, PPV may be in the inconclusive "gray zone" (between 9% and 13%) in approximately 25% of patients during general anaesthesia. [23] . Its utility may be even worse with regard to intensive care units. Mahjoub et al. demonstrated that a very low percentage (only 2%) of patients satisfied the validity criteria for using PPV [24] in this setting. Finally, we should keep in mind that such hemodynamic monitoring systems are simply measurement tools and, to quote Dr. Michael Pinsky: "no monitoring device, no matter how simple or sophisticated, will improve patients' outcome unless coupled to a treatment which itself improves outcome" [25] . Thus, all of these minimally invasive CO monitoring devices only have the ability to improve postoperative patients' outcome if they are integrated into protocols that guide appropriate therapeutic interventions.
Perioperative Goal directed therapy is a general concept of managing fluids and/or vasopressor agents using these minimally invasive technologies, coupled with predefined treatment algorithms, in order to achieve physiological targets with the ultimate goal of optimizing tissue oxygen delivery [26] . This concept, based on the optimization of flow parameters and/or preload responsiveness indices, has consistently been shown to be useful in decreasing postoperative morbidity, reducing hospital length of stay [27−32] and hospital costs [33] in patients undergoing high risk surgery. As noted above, the large amount of evidence supporting GDT is currently so robust that clinical societies in the United Kingdom [34] , France [35] and Europe [36] have established relevant national guidelines. These professional societies strongly consider GDT as the best practice for perioperative hemodynamic optimization in high risk surgical patients. The most significant progress, however, has been made in the United Kingdom where the National Institute of Health and Clinical Excellence has recommended the specific use of oesophageal Doppler or similar fluid responsiveness monitoring devices to titrate fluid administration during the perioperative period in high risk surgery [37] . Additionally, many UK health care trusts currently receive payment to incentivize the implementation of this strategy as standard of care for at least 80% of eligible patients [37] . Hopefully, similar national guidelines will be created in the future by other countries looking for decreased perioperative morbidity.
GdT wiThin erAs And psh models: where we should Go?
Progress towards a more standardized approach for optimal perioperative fluid managements has already been made. Moreover, such GDT approaches can be applied alone or as a part of the newer comprehensive practices, such as the Enhanced Recovery After Surgery [38] programs (ERAS) in Europe and the Perioperative Surgical Home model (PSH) [39−41] in the United States, both of which emphasize the importance of "precise fluid management" during surgery [42, 43] . The Enhanced Recovery After Surgery (ERAS) program initiated in Europe has evolved considerably over the past few years and is gaining traction throughout the world [44] . The aim of this program is to apply best practices to high-risk surgical patients, which requires the participation of all clinicians involved in relevant patient care. In the United States, the perioperative surgical home (PSH) model has recently been gaining momentum. It is defined as a "patient-centered and team-based approach that guides the patient throughout the entire surgical experience by developing protocols and guidelines to improve perioperative management that also incorporates the anesthesiologist into a central management role. " This philosophy is aimed at reducing variability and mistakes through better coordination of care and increased evidence-based standardization. This PSH design may soon become the standard of care in the US as it has been shown to result in improved clinical outcomes [45, 46] . Unfortunately, despite strong published data highlighting the clinical and economic benefits of GDT [28] , translating this evidence to the bedside remains a challenge and is further complicated as it is inconsistently applied [9, 47] . Unfortunately, it has been estimated that only around 50% of participating patients receive recommended therapies [48, 49] . Specific to fluid management, there remains significant variability within fluid administration practices among clinicians which likely contributes to observed variability in surgical outcomes [50] . One possible reason for low utilization is that protocols are intrinsically both time and attention intensive; even under optimal study conditions, clinicians' compliance to similar protocols is inconsistent and often not greater than 50% [51−53] . Another explanation for slow adoption may be the moderate learning curve which accompanies such protocols when implemented correctly in practice. The "OPTIMISE" trial recently demonstrated that such a learning curve, combined with the inherent difficulty adhering to a new protocol, are both significant weakness of our current approach to the larger utilization of GDT [54] . This is the largest multicenter trial to date reporting the results of high-risk patients undergoing gastrointestinal surgery who were randomized to receive either standard care or GDT. Although the results of this study showed no difference in the primary outcome between the two groups, the results became significant when they were adjusted for protocol adherence, with GDT leading to fewer postoperative complications than the control group. As the first 10 patients of each centre were excluded after this adjustment, one can likely presume that a large learning curve exists and that the protocols are not necessarily easy to follow in an operating room already saturated with monitors, tasks, and frequent distractions. A final potential reason for minimal compliance may be explained by the fact that GDT strategies have never been well standardized and today no single consensus on the use of GDT has been widely accepted across the published literature [55] . Furthermore, studies of GDT have utilized a plethora of different techniques, algorithms and minimally invasive devices making it difficult for clinicians to choose an approach and leading to confusion about how and when to use each technique correctly.
AuTomATion And closed-loop TechnoloGy: where Are we GoinG in The neAr FuTure?
With the above understanding of the current state of GDT, the natural next questions becomes whether we can create a link between such evidence-based recommendations and consistent clinical adoption at the bedside. Anaesthesiologists are well-known to be routinely confronted with computer based-systems in their daily management and, as a result, are increasingly comfortably with relevant computational advancements [56] . As increasingly sophisticated monitoring devices are developed, however, anaesthesiologist may feel overwhelmed by the constantly growing quantity of displayed hemodynamics, especially if the minutia of a GDT protocol has to be followed very closely. A natural extension, using an engineering paradigm, would be to automate the aspects of fluid administration and integrate pre-defined algorithms into applicable computer hardware [57] . Indeed, a closed-loop hemodynamic system offers one an elegant and suitable way to integrate these different data streams in order to decrease clinical distractions and increase compliance.
Very briefly, a closed-loop system is a system wherein a controller monitors one or multiple variables and adjusts one or more interventions using a feedback process [57] . A simple example would be a thermostat adjusting heating and cooling functions based on real time measurements of temperature. A clinical example would be the completely automated closed-loop fluid administration system recently developed by Dr. Cannesson and Dr. Rinehart at UC Irvine, which is designed to assist anaesthesiologists by automating goal directed fluid therapy protocols. Such automation would decrease unnecessary distractions and optimize fluid delivery using well establish protocols. This closed-loop system uses flow-based parameters (stroke volume, cardiac output) and/or dynamic parameters of fluid responsiveness (pulse pressure variation, stroke volume variation) collected from a minimally invasive CO monitoring device (EV-1000, Edwards Lifesciences, Irvine, USA) to automatically control fluid boluses in order to apply GDT protocols consistently with minimal provider workload (Fig. 2) . The closed-loop software and hardware can easily track each bolus that has been given and, using patient specific accumulated data, can project the anticipated benefit of an additional bolus. This approach has been extensively tested in simulation [58, 59] , engineering [60] , and animal [61] studies before being tested in clinical practice.
After accounting for expected risks, what increased benefits could this system bring for anaesthesiologists in the operating room?
Firstly, the automated closed-loop system has been shown to be more precise in monitoring clinical variables than human practitioners, as well as maintaining such hemodynamic parameters more steadily and consistently than trained anaesthesiologists [58, 59] in simulated and animal haemorrhage models [61] . This difference has been explained by an earlier onset of fluid administration. Indeed, the closed-loop software and hardware was more adept at responding to multiple variables indicating a need for fluid therapy. This automated administration more quickly optimizes intraoperative stroke volume in order to bring the patient onto the plateau of the Frank-Starling curve when compared to anaesthesiologists acting alone.
Secondly, the closed-loop algorithm can decrease individual operator variability in managing fluid titration and thus help standardize goal directed fluid therapy delivery across clinicians and institutions. Reducing variability has been shown to be a key factor in improving medical quality and patient safety [62] . Concordantly, the automated system can facilitate the implementation of high-quality, standardized, goal directed fluid therapy protocols with a high adherence when compared to standard practice. By optimizing patients' fluid status using a very mundane and repetitive task (titration of fluid), especially during long surgery cases, such a system will systemically reduce overall provider workload, thus allowing more time for the anaesthesiologist to focus his or her attention on other, more pertinent, medical decisions.
Lastly, along with reducing variability and allowing for increased provider focus, such a system will likely decrease medical errors, which have been shown to be a source of preventable morbidity in anaesthesiology and critical care [51, 63] .
Two clinical studies have shown the feasibility of a closed-loop system for providing high-compliance goal directed fluid therapy while using a minimally invasive, and even a completely non-invasive CO monitoring system in patients undergoing high-risk [64] and moderate-risk [65] surgeries, respectively. The automated fluid administration systems were deemed successful if the patient spent more than 85% of intraoperative time in a preload-independent state (defined as a pulse pressure variation < 13 % and/or a cardiac index > 2.5 L min -1 m -2 ). A more recent study [66] , comparing closed loop assisted versus manual goal directed fluid therapy management during major abdominal surgery, showed that closed-loop assistance also resulted in a greater portion of case time spent in a preload independent state when compared to manual delivery of goal directed fluid therapy, without any difference in total fluid volumes administered to patients. Further trials are still needed to examine the benefits of this closed-loop system on clinical outcomes.
Recent advances in clinical technology have likely disproportionately benefitted the practice of anaesthesia when compared to other specialties. The time for bridging long-standing automated engineering practices with such improvements in clinical monitoring is fast approaching. One common question posed when providers hear about this technology has been, "Will this automation eventually replace me in the operating room?" As we have seen with most emergent automated processes, a more appropriate question should be, "What benefit can automation have on my daily clinical practice and how can this system improve patient care while also mastering mundane clinical tasks?" Although this question has not yet been fully answered, it is now being worked on at an unprecedented rate. While this field will continue to train experts in physiology, it will also shift to create anaesthesiologists who are increasingly adept at guiding patients throughout the entire perioperative process. Closed-loop technology, alongside the knowledge and expertise of a well-trained physician, will help ensure that a higher level of standardization, safer individualized references:
